Tumour immunology: Cell cycle inhibitors boost tumour immunogenicity
Nature Reviews Immunology 17, 529 (2017).
doi:10.1038/nri.2017.104
Author: Kirsty Minton
Cyclin-dependent kinase inhibitors promote tumour regression by increasing antigen presentation and decreasing immune regulation.
Source: Nature Reviews Immunology - Category: Allergy & Immunology Authors: Kirsty Minton Tags: Research Highlight Source Type: research
More News: Allergy & Immunology